Table 1. Combined analysis of association with SLE in the Swedish discovery and confirmation cohortsa.
| Gene | CHR | SNPb | Basepair | Minor/major alleles | MAF cases | MAF controls | Pc | Risk allele | OR (95% CI) |
|---|---|---|---|---|---|---|---|---|---|
| IKBKE | 1 | rs1539243 | 204 714 410 | T/C | 0.16 | 0.18 | 0.031 | C | 1.19 (1.02–1.39) |
| IKBKE | 1 | rs17433930 | 204 719 362 | G/A | 0.07 | 0.09 | 0.013 | A | 1.33 (1.06–1.67) |
| TANK | 2 | rs3754974 | 161 721 201 | G/A | 0.05 | 0.04 | 0.0087 | G | 1.44 (1.09–1.89) |
| TANK | 2 | rs1267075 | 161 768 063 | G/A | 0.19 | 0.18 | 0.75 | G | 1.02 (0.88–1.19) |
| STAT1 | 2 | rs2030171 | 191 577 408 | A/G | 0.35 | 0.29 | 1.2E−05 | A | 1.31 (1.16–1.49) |
| STAT1 | 2 | rs16833172 | 191 584 314 | A/G | 0.04 | 0.03 | 0.015 | A | 1.51 (1.09–2.09) |
| IL8 | 4 | rs4694178 | 74 831 552 | C/A | 0.52 | 0.46 | 5.2E−05 | C | 1.26 (1.12–1.42) |
| NRP1 | 10 | rs734187 | 33 524 702 | A/G | 0.24 | 0.24 | 0.67 | A | 1.03 (0.90–1.18) |
| NRP1 | 10 | rs1331314 | 33 564 687 | G/C | 0.11 | 0.10 | 0.32 | G | 1.11 (0.92–1.34) |
| NRP1 | 10 | rs2073320 | 33 593 263 | A/G | 0.38 | 0.37 | 0.42 | A | 1.05 (0.93–1.18) |
| TRAF6 | 11 | rs5030482 | 36 466 602 | C/T | 0.12 | 0.14 | 0.0094 | T | 1.25 (1.05–1.49) |
| TRAF6 | 11 | rs5030472 | 36 470 362 | T/C | 0.09 | 0.12 | 0.013 | C | 1.28 (1.05–1.55) |
| STAT5B | 17 | rs6503691 | 37 647 616 | T/C | 0.09 | 0.10 | 0.44 | C | 1.08 (0.88–1.32) |
| PIAS4 | 19 | rs2289863 | 3 979 783 | C/T | 0.27 | 0.29 | 0.19 | T | 1.09 (0.96–1.25) |
Abbreviations: CI, confidence Interval; MAF, minor Allele Frequency; OR, odds ratio; SNP, single-nucleotide polymorphism.
826 Swedish cases and 1835 controls genotyped in the discovery and replication phases including controls genotyped on the 1M chip.
Genotypes for rs17433930, rs3754974, rs2030171, rs16833172, rs4694178, rs734187 and rs1331314 were imputed in the Swedish controls genotyped on the 1M chip.
P-values calculated using SNPtest.
P-values <0.05 are indicated in bold.